BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 22775567)

  • 1. Inhibition of GSK-3β enhances neural differentiation in unrestricted somatic stem cells.
    Dastjerdi FV; Zeynali B; Tafreshi AP; Shahraz A; Chavoshi MS; Najafabadi IK; Vardanjani MM; Atashi A; Soleimani M
    Cell Biol Int; 2012 Nov; 36(11):967-72. PubMed ID: 22775567
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of glycogen synthase kinase-3beta attenuates glucocorticoid-induced bone loss.
    Wang FS; Ko JY; Weng LH; Yeh DW; Ke HJ; Wu SL
    Life Sci; 2009 Nov; 85(19-20):685-92. PubMed ID: 19782693
    [TBL] [Abstract][Full Text] [Related]  

  • 3. GSK-3β inhibition promotes engraftment of ex vivo-expanded hematopoietic stem cells and modulates gene expression.
    Ko KH; Holmes T; Palladinetti P; Song E; Nordon R; O'Brien TA; Dolnikov A
    Stem Cells; 2011 Jan; 29(1):108-18. PubMed ID: 20960517
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of GSK-3beta promotes survival and proliferation of megakaryocytic cells through a beta-catenin-independent pathway.
    Soda M; Willert K; Kaushansky K; Geddis AE
    Cell Signal; 2008 Dec; 20(12):2317-23. PubMed ID: 18804163
    [TBL] [Abstract][Full Text] [Related]  

  • 5. GSK-3β inhibition preserves naive T cell phenotype in bone marrow reconstituted mice.
    Shen S; Klamer G; Xu N; O'Brien TA; Dolnikov A
    Exp Hematol; 2013 Dec; 41(12):1016-27.e1. PubMed ID: 24018603
    [TBL] [Abstract][Full Text] [Related]  

  • 6. GSK-3beta inhibition/beta-catenin stabilization in ventral midbrain precursors increases differentiation into dopamine neurons.
    Castelo-Branco G; Rawal N; Arenas E
    J Cell Sci; 2004 Nov; 117(Pt 24):5731-7. PubMed ID: 15522889
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel indolylmaleimide acts as GSK-3beta inhibitor in human neural progenitor cells.
    Schmöle AC; Brennführer A; Karapetyan G; Jaster R; Pews-Davtyan A; Hübner R; Ortinau S; Beller M; Rolfs A; Frech MJ
    Bioorg Med Chem; 2010 Sep; 18(18):6785-95. PubMed ID: 20708937
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of cytoplasmic GSK-3β increases cisplatin resistance through activation of Wnt/β-catenin signaling in A549/DDP cells.
    Gao Y; Liu Z; Zhang X; He J; Pan Y; Hao F; Xie L; Li Q; Qiu X; Wang E
    Cancer Lett; 2013 Aug; 336(1):231-9. PubMed ID: 23673211
    [TBL] [Abstract][Full Text] [Related]  

  • 9. GSK-3β: a signaling pathway node modulating neural stem cell and endothelial cell interactions.
    Li Q; Michaud M; Canosa S; Kuo A; Madri JA
    Angiogenesis; 2011 May; 14(2):173-85. PubMed ID: 21253820
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Curcumin activates Wnt/β-catenin signaling pathway through inhibiting the activity of GSK-3β in APPswe transfected SY5Y cells.
    Zhang X; Yin WK; Shi XD; Li Y
    Eur J Pharm Sci; 2011 Apr; 42(5):540-6. PubMed ID: 21352912
    [TBL] [Abstract][Full Text] [Related]  

  • 11. GSK-3β suppresses the proliferation of rat hepatic oval cells through modulating Wnt/β-catenin signaling pathway.
    Ji XK; Xie YK; Zhong JQ; Xu QG; Zeng QQ; Wang Y; Zhang QY; Shan YF
    Acta Pharmacol Sin; 2015 Mar; 36(3):334-42. PubMed ID: 25661318
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activation of TGFβ1 signaling enhances early dopaminergic differentiation in unrestricted somatic stem cells.
    Khanghahi AM; Zeynali B; Akhlaghpoor A; Tafreshi AP; Krieglstein K
    Neurosci Lett; 2014 Nov; 583():60-4. PubMed ID: 25233862
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Wnt/β-catenin signaling pathway upregulates c-Myc expression to promote cell proliferation of P19 teratocarcinoma cells.
    Zhang S; Li Y; Wu Y; Shi K; Bing L; Hao J
    Anat Rec (Hoboken); 2012 Dec; 295(12):2104-13. PubMed ID: 22976998
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ROCK2 regulates bFGF-induced proliferation of SH-SY5Y cells through GSK-3β and β-catenin pathway.
    Boku S; Nakagawa S; Toda H; Kato A; Takamura N; Omiya Y; Inoue T; Koyama T
    Brain Res; 2013 Jan; 1492():7-17. PubMed ID: 23211630
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of lymphoma cell proliferation by peroxisomal proliferator-activated receptor-γ ligands via Wnt signaling pathway.
    Liu JJ; Dai XJ; Xu Y; Liu PQ; Zhang Y; Liu XD; Fang ZG; Lin DJ; Xiao RZ; Huang RW; Huang HQ
    Cell Biochem Biophys; 2012 Jan; 62(1):19-27. PubMed ID: 21837368
    [TBL] [Abstract][Full Text] [Related]  

  • 16. GSK-3β inhibition promotes early engraftment of ex vivo-expanded haematopoietic stem cells.
    Dolnikov A; Xu N; Shen S; Song E; Holmes T; Klamer G; O'Brien TA
    Cell Prolif; 2014 Apr; 47(2):113-23. PubMed ID: 24517125
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lithium stimulates human bone marrow derived mesenchymal stem cell proliferation through GSK-3β-dependent β-catenin/Wnt pathway activation.
    Zhu Z; Yin J; Guan J; Hu B; Niu X; Jin D; Wang Y; Zhang C
    FEBS J; 2014 Dec; 281(23):5371-89. PubMed ID: 25265417
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enhanced Wnt/β-catenin signalling during tooth morphogenesis impedes cell differentiation and leads to alterations in the structure and mineralisation of the adult tooth.
    Aurrekoetxea M; Lopez J; García P; Ibarretxe G; Unda F
    Biol Cell; 2012 Oct; 104(10):603-17. PubMed ID: 22671936
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nuclear GSK-3beta inhibits the canonical Wnt signalling pathway in a beta-catenin phosphorylation-independent manner.
    Caspi M; Zilberberg A; Eldar-Finkelman H; Rosin-Arbesfeld R
    Oncogene; 2008 Jun; 27(25):3546-55. PubMed ID: 18223684
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glycogen synthase kinase-3beta inhibition preserves hematopoietic stem cell activity and inhibits leukemic cell growth.
    Holmes T; O'Brien TA; Knight R; Lindeman R; Shen S; Song E; Symonds G; Dolnikov A
    Stem Cells; 2008 May; 26(5):1288-97. PubMed ID: 18323411
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.